Print | Need Larger Text?

Incident Report

Subform I: General Information

1. Report Type.

New incident report

Incident Report Number: 2023-2592

2. Registrant Information.

Registrant Reference Number: 2023-07

Registrant Name (Full Legal Name no abbreviations): BASF Canada Inc.

Address: 5025 Creekbank Road, Building A, 2nd Floor

City: Mississauga

Prov / State: Ontario

Country: Canada

Postal Code: L4W 0B6

3. Select the appropriate subform(s) for the incident.

Scientific Study

4. Date registrant was first informed of the incident.

5. Location of incident.

6. Date incident was first observed.

Product Description

7. a) Provide the active ingredient and, if available, the registration number and product name (include all tank mixes). If the product is not registered provide a submission number.

PMRA Registration No.       PMRA Submission No.       EPA Registration No. Unknown

Product Name: BAS 872 00 H

• Active Ingredient(s)
  • DICAMBA (PRESENT AS ACID, AMINE SALT, ESTER, OR SODIUM SALT)
  • IMAZETHAPYR
  • PYROXASULFONE

7. b) Type of formulation.

Application Information

8. Product was applied?

Unknown

9. Application Rate.

10. Site pesticide was applied to (select all that apply).

11. Provide any additional information regarding application (how it was applied, amount applied, the size of the area treated etc).

To be determined by Registrant

12. In your opinion, was the product used according to the label instructions?

Unknown

Subform VII: Scientific Study

1. Study Reference

Title BAS 872 00 H - Seedling Emergence Test

Date 19-APR-22

2. a) Is an extension needed to translate the document?

No

3. Type of incident identified in the study

Increased health or environmental risk

4. Describe the incident identified in the study (e.g. study demonstrates an increased risk to non-Hodgkin's Lymphoma after exposure to pesticide X)

Seedling emergence study conducted with formulation containing Dicamba as BAPMA salt, pyroxasulfone and imazethapyr. Formulation not currently registered in Canada. Various species tested.

5. a) Was the study discontinued before completion?

No

5. b) Provide the reason for discontinuation

6. If the study is ongoing, what is the expected completion date?

For Registrant use only

7. Provide supplemental information here

Study conducted with formulation containing Dicamba as BAPMA salt, pyroxasulfone and imazethapyr. Formulation not currently registered in Canada. Various species tested, unclear if greater env tox concern compared with previous data